Fuller & Thaler Asset Management
LGND icon

Fuller & Thaler Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Fuller & Thaler Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-71,558
Closed -$6.06M – 468
2018
Q4 		$6.06M Buy
+71,558
New +$6.06M 0.09% 168